Literature DB >> 29294232

A combined diffusion tensor imaging and Ki-67 labeling index study for evaluating the extent of tumor infiltration using the F98 rat glioma model.

Kai Wang1, Tingting Ha2, Xuzhu Chen3, Shaowu Li4, Lin Ai1, Jun Ma3, Jianping Dai5.   

Abstract

Diffusion tensor imaging (DTI) has been proven to be a sophisticated and useful tool for the delineation of tumors. In the present study, we investigated the predictive role of DTI compared to other magnetic resonance imaging (MRI) techniques in combination with Ki-67 labeling index in defining tumor cell infiltration in the peritumoral regions of F98 glioma-bearing rats. A total of 29 tumor-bearing Fischer rats underwent T2-weighted imaging, contrast-enhanced T1-weighted imaging, and DTI of their brain using a 7.0-T MRI scanner. The fractional anisotropy (FA) ratios were correlated to the Ki-67 labeling index using the Spearman correlation analysis. A receiver operating characteristic curve (ROC) analysis was established to evaluate parameters with sensitivity and specificity in order to identify the threshold values for predicting tumor infiltration. Significant correlations were observed between the FA ratios and Ki-67 labeling index (r = - 0.865, p < 0.001). The ROC analysis demonstrated that the apparent diffusion coefficient (ADC) and FA ratios could predict 50% of the proliferating cells in the regions of interest (ROI), with a sensitivity of 88.1 and 81.3%, and a specificity of 86.2 and 90.2%, respectively (p < 0.001). Meanwhile, the two ratios could also predict 10% of the proliferating cells in the ROI, with a sensitivity of 82.5 and 94.9%, and a specificity of 100 and 88.9%, respectively (p < 0.001). The present study demonstrated that the FA ratios are closely correlated with the Ki-67 labeling index. Furthermore, both ADC and FA ratios, derived from DTI, were useful for quantitatively predicting the Ki-67 labeling of glioma cells.

Entities:  

Keywords:  Diffusion tensor imaging; Glioma; Ki-67; Rat model; Tumor infiltration

Mesh:

Substances:

Year:  2018        PMID: 29294232     DOI: 10.1007/s11060-017-2734-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  50 in total

Review 1.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas.

Authors:  Rolf F Barth; Balveen Kaur
Journal:  J Neurooncol       Date:  2009-04-21       Impact factor: 4.130

2.  Longitudinal diffusion tensor imaging in a rat brain glioma model.

Authors:  Silvia Lope-Piedrafita; Maria L Garcia-Martin; Jean-Philippe Galons; Robert J Gillies; Theodore P Trouard
Journal:  NMR Biomed       Date:  2008-10       Impact factor: 4.044

3.  Survival analysis of 205 patients with glioblastoma multiforme: clinical characteristics, treatment and prognosis in China.

Authors:  Xiangyu Ma; Yafeng Lv; Jia Liu; Donghai Wang; Qibing Huang; Xinyu Wang; Gang Li; Shujun Xu; Xingang Li
Journal:  J Clin Neurosci       Date:  2009-09-29       Impact factor: 1.961

4.  Differential molecular genetic analysis in glioblastoma multiforme of long- and short-term survivors: a clinical study in Chinese patients.

Authors:  Guo-Bin Zhang; Xiang-Li Cui; Da-Li Sui; Xiao-Hui Ren; Zhe Zhang; Zhong-Cheng Wang; Song Lin
Journal:  J Neurooncol       Date:  2013-03-15       Impact factor: 4.130

5.  Integrative, multimodal analysis of glioblastoma using TCGA molecular data, pathology images, and clinical outcomes.

Authors:  Jun Kong; Lee A D Cooper; Fusheng Wang; David A Gutman; Jingjing Gao; Candace Chisolm; Ashish Sharma; Tony Pan; Erwin G Van Meir; Tahsin M Kurc; Carlos S Moreno; Joel H Saltz; Daniel J Brat
Journal:  IEEE Trans Biomed Eng       Date:  2011-09-23       Impact factor: 4.538

6.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

7.  Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy.

Authors:  June L Chan; Susan W Lee; Benedick A Fraass; Daniel P Normolle; Harry S Greenberg; Larry R Junck; Stephen S Gebarski; Howard M Sandler
Journal:  J Clin Oncol       Date:  2002-03-15       Impact factor: 44.544

8.  Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.

Authors:  Stanley Lu; Daniel Ahn; Glyn Johnson; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

9.  IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.

Authors:  Gergana Stancheva; Teodora Goranova; Maria Laleva; Margarita Kamenova; Atanaska Mitkova; Nikolay Velinov; George Poptodorov; Vanio Mitev; Radka Kaneva; Nikolay Gabrovsky
Journal:  Biomed Res Int       Date:  2014-04-24       Impact factor: 3.246

10.  Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?

Authors:  S J Price; N G Burnet; T Donovan; H A L Green; A Peña; N M Antoun; J D Pickard; T A Carpenter; J H Gillard
Journal:  Clin Radiol       Date:  2003-06       Impact factor: 2.350

View more
  2 in total

1.  Perampanel Add-on to Standard Radiochemotherapy in vivo Promotes Neuroprotection in a Rodent F98 Glioma Model.

Authors:  Falko Lange; Jens Hartung; Clara Liebelt; Julius Boisserée; Tobias Resch; Katrin Porath; Julia Hörnschemeyer; Gesine Reichart; Tina Sellmann; Valentin Neubert; Stephan Kriesen; Guido Hildebrandt; Elisabeth Schültke; Rüdiger Köhling; Timo Kirschstein
Journal:  Front Neurosci       Date:  2020-11-30       Impact factor: 4.677

2.  Diagnosis of Invasive Meningioma Based on Brain-Tumor Interface Radiomics Features on Brain MR Images: A Multicenter Study.

Authors:  Dongdong Xiao; Zhen Zhao; Jun Liu; Xuan Wang; Peng Fu; Jehane Michael Le Grange; Jihua Wang; Xuebing Guo; Hongyang Zhao; Jiawei Shi; Pengfei Yan; Xiaobing Jiang
Journal:  Front Oncol       Date:  2021-08-20       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.